Triaging and Prioritizing Patients with Multiple Myeloma

Opinion
Video

Experts on multiple myeloma provide clinical insights on how they triage and prioritize patients to best utilize available resources.

Recent Videos
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
4 experts in this video
4 experts in this video
Related Content